The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Association Between Human Fetuin-A and the Metabolic Syndrome: Data From the Heart and Soul Study
Open accessAbstract
Background— Fetuin-A is a multifunctional hepatic secretory protein that inhibits the action of insulin in experimental animals. We evaluated the association between human serum fetuin-A and the metabolic syndrome (MetS) in a cohort of persons with coronary artery disease. Methods and Results— We defined MetS by the National Cholesterol Education Program criteria among 711 nondiabetic outpatients with coronary artery disease. The mean age was 67 years, and 82% were male. We divided participants into quartiles by serum fetuin-A concentrations. A total of 45% of participants (80 of 177) in the highest quartile of fetuin-A had MetS compared with 24% of participants (42 of 177) in the lowest quartile (odds ratio, 2.7; 95% confidence interval, 1.7 to 4.2; P <0.001). This association persisted after adjustment for potential confounding variables, including hypertension, body mass index, and inflammatory biomarkers (adjusted odds ratio, 2.0; 95% confidence interval, 1.1 to 3.5; P =0.02). Higher fetuin-A quartiles were also strongly and independently associated with higher low-density lipoprotein, non–high-density lipoprotein (HDL), and triglyceride concentrations and lower HDL concentrations (all P <0.01). Conclusions— Higher human fetuin-A concentrations are strongly associated with MetS and an atherogenic lipid profile. Future studies should evaluate whether fetuin-A predicts coronary artery disease risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Jyothi Kumar, M. V., & Chippada, A. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (1957) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,208
Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292
Ridker, P. M. (2001) · Circulation · doi:10.1161/01.cir.103.13.1813 · Cited by 1,402
Ketteler, M., Bongartz, P., Westenfeld, R., Wildberger, J. E., Mahnken, A. H., Böhm, R., Metzger, T., Wanner, C., Jahnen-Dechent, W., & Floege, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12710-9 · Cited by 910
Self-citationCheng, G. C., Loree, H. M., Kamm, R. D., Fishbein, M. C., & Lee, R. T. (1993) · Circulation · doi:10.1161/01.cir.87.4.1179 · Cited by 797
Depressive Symptoms and Health-Related Quality of Life: The Heart and Soul Study
Ruo, B., Rumsfeld, J. S., Hlatky, M. A., Liu, H., Browner, W. S., & Whooley, M. A. (2003) · JAMA · doi:10.1001/jama.290.2.215 · Cited by 747
Self-citationRidker, P. M., Rifai, N., Cook, N. R., Bradwin, G., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.3.326 · Cited by 744
Vionnet, N., Hani, E. H., Dupont, S., Gallina, S., Francke, S., Dotte, S., De Matos, F., Durand, E., Leprêtre, F., Lecoeur, C., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/316887 · Cited by 680
Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome
Kissebah, A. H., Sonnenberg, G. E., Myklebust, J., Goldstein, M., Broman, K., James, R. G., Marks, J. A., Krakower, G. R., Jacob, H. J., Weber, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14478 · Cited by 638
The Impact of Calcification on the Biomechanical Stability of Atherosclerotic Plaques
Huang, H., Virmani, R., Younis, H., Burke, A. P., Kamm, R. D., & Lee, R. T. (2001) · Circulation · doi:10.1161/01.cir.103.8.1051 · Cited by 598
Lewis, G. F., Uffelman, K. D., Szeto, L. W., Weller, B., & Steiner, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117633 · Cited by 502
Components of the Metabolic Syndrome and Risk of Cardiovascular Disease and Diabetes in Beaver Dam
Klein, B. E. K., Klein, R., & Lee, K. E. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1790 · Cited by 468
Schinke, T., Amendt, C., Trindl, A., Pöschke, O., Müller-Esterl, W., & Jahnen-Dechent, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20789 · Cited by 356
Improved Insulin Sensitivity and Resistance to Weight Gain in Mice Null for the Ahsg Gene
Mathews, S. T., Singh, G. P., Ranalletta, M., Cintron, V. J., Qiang, X., Goustin, A. S., Jen, K.-L. C., Charron, M. J., Jahnen-Dechent, W., & Grunberger, G. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2450 · Cited by 342
Lebreton, J. P., Joisel, F., Raoult, J. P., Lannuzel, B., Rogez, J. P., & Humbert, G. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109551 · Cited by 333
Insulin Regulation of Lipolysis in Nondiabetic and IDDM Subjects
Jensen, M. D., Caruso, M., Heiling, V., & Miles, J. M. (1989) · Diabetes · doi:10.2337/diab.38.12.1595 · Cited by 331
Auberger, P., Falquerho, L., Contreres, J. O., Pages, G., Cam, G. L., Rossi, B., & Cam, A. L. (1989) · Cell · doi:10.1016/0092-8674(89)90098-6 · Cited by 321
Brinton, E. A., Eisenberg, S., & Breslow, J. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115028 · Cited by 259
Cloning and Targeted Deletion of the Mouse Fetuin Gene
Jahnen-Dechent, W., Schinke, T., Trindl, A., Müller-Esterl, W., Sablitzky, F., Kaiser, S., & Blessing, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31496 · Cited by 244
Srinivas, P. R. (1993) · Molecular Endocrinology · doi:10.1210/me.7.11.1445 · Cited by 243
Deedwania, P. C. (2004) · Circulation · doi:10.1161/01.cir.0000110642.73995.bf · Cited by 236
Relationship of Clinical Presentation and Calcification of Culprit Coronary Artery Stenoses
Beckman, J. A., Ganz, J., Creager, M. A., Ganz, P., & Kinlay, S. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.095554 · Cited by 201
Price, P. A., Thomas, G. R., Pardini, A. W., Figueira, W. F., Caputo, J. M., & Williamson, M. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106366200 · Cited by 179
The nucleotide and partial amino acid sequences of rat fetuin
Rauth, G., Poeschke, O., Fink, E., Eulitz, M., Tippmer, S., Kellerer, M., Häring, H.-U., Nawratil, P., Haasemann, M., Jahnen‐Dechent, W., et al. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb16663.x · Cited by 134
Ix, J. H., Shlipak, M. G., Liu, H. H., Schiller, N. B., & Whooley, M. A. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000095642.25603.7a · Cited by 117
Self-citationBeattie, M. S., Shlipak, M. G., Liu, H., Browner, W. S., Schiller, N. B., & Whooley, M. A. (2003) · Circulation · doi:10.1161/01.cir.0000044387.23578.e9 · Cited by 73
Self-citationBovine fetuin is an inhibitor of insulin receptor tyrosine kinase
Mathews, S. T., Srinivas, P. R., Leon, M. A., & Grunberger, G. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00737-6 · Cited by 68
Kalabay, L., Chavin, K. D., Lebreton, J.-P., Robinson, K. A., Buse, M., & Arnaud, P. (1998) · Hormone and Metabolic Research · doi:10.1055/s-2007-978822 · Cited by 47
Haasemann, M., Nawratil, P., & Müller‐Esterl, W. (1991) · Biochemical Journal · doi:10.1042/bj2740899 · Cited by 31
Baculoviral Expression of a Natural Inhibitor of the Human Insulin Receptor Tyrosine Kinase
Srinivas, P. R., Goustin, A. S., & Grunberger, G. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1417 · Cited by 19
Cintrón, V. J., Ko, M. S. H., Chi, K. D., Gross, J. P., Srinivas, P. R., Goustin, A. S., & Grunberger, G. (2000) · Journal of Diabetes Research · doi:10.1155/edr.2000.249 · Cited by 17
Grunberger, G. (2010) · Taylor & Francis eBooks · doi:10.4324/9780203302958_chapter_15 · Cited by 5
Cited by
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., & Assi, H. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020786 · Cited by 1,441
The role of hepatokines in metabolism
Stefan, N., & Häring, H.-U. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.258 · Cited by 500
Fetuin-A Regulation of Calcified Matrix Metabolism
Jahnen-Dechent, W., Heiss, A., Schäfer, C., & Ketteler, M. (2011) · Circulation Research · doi:10.1161/circresaha.110.234260 · Cited by 385
Self-citationPlasma fetuin-A levels and the risk of type 2 diabetes
Stefan, N., Fritsche, A., Weikert, C., Boeing, H., Joost, H.-G., Häring, H.-U., & Schulze, M. B. (2008) · Diabetes · doi:10.2337/db08-0538 · Cited by 379
Ix, J. H., & Sharma, K. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009080820 · Cited by 348
Self-citation
Metadata
- Authors
- Ix, J. H., Shlipak, M. G., Brandenburg, V. M., Ali, S., Ketteler, M., & Whooley, M. A.
- Venue
- Circulation
- Published
- 2006-04-11
- Volume
- 113
- Issue
- 14
- Pages
- 1760-1767
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2133281319
- Cited by
- 316
- References
- 40
- FWCI
- 11.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.